Location · The Bronx, NY
Clinical trials in The Bronx, NY
157 recruiting studies have a site in The Bronx, and 34 of them accept healthy volunteers.
157 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Sanofi
- Location
- The Bronx, NY + 16 other US sites
- Eligibility basics
- Ages 16–75
- RecruitingPhase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche
- Location
- The Bronx, NY + 67 other US sites
- Eligibility basics
- Ages 50–90
- Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Supira Medical
- Location
- The Bronx, NY + 24 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Medtronic Cardiac Ablation Solutions
- Location
- The Bronx, NY + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Eli Lilly and Company
- Location
- The Bronx, NY + 11 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
Spyre Therapeutics, Inc.
- Location
- The Bronx, NY + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
- Location
- The Bronx, NY + 27 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Biotronik, Inc.
- Location
- The Bronx, NY + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- The Bronx, NY + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Cabaletta Bio
- Location
- The Bronx, NY + 29 other US sites
- Eligibility basics
- Ages 6–75
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Novartis Pharmaceuticals
- Location
- The Bronx, NY + 16 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Pfizer
- Location
- The Bronx, NY + 76 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sanofi
- Location
- The Bronx, NY + 20 other US sites
- Eligibility basics
- Ages 10–65
- Recruiting
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Artivion Inc.
- Location
- The Bronx, NY + 21 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Bausch Health Americas, Inc.
- Location
- The Bronx, NY + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
MapLight Therapeutics
- Location
- The Bronx, NY + 41 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc.
- Location
- The Bronx, NY + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Pfizer
- Location
- The Bronx, NY + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Boehringer Ingelheim
- Location
- The Bronx, NY + 91 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Biogen
- Location
- The Bronx, NY + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- The Bronx, NY + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- The Bronx, NY + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- The Bronx, NY + 80 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- The Bronx, NY + 17 other US sites
- Eligibility basics
- Any age listed